US2012149717A1PendingUtilityA1

Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof

39
Assignee: BROWN WILLIAMPriority: Aug 2, 2004Filed: Feb 21, 2012Published: Jun 14, 2012
Est. expiryAug 2, 2024(expired)· nominal 20-yr term from priority
A61P 25/04C07D 295/155A61P 25/16A61P 25/22A61P 25/24A61K 31/495
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compounds of general formula: as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain, depression and anxiety.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled) 
     
     
         17 . A compound 4-{(R)-(3-aminophenyl)[4-(4-fluorobenzyl)piperazin-1-yl]methyl}-N,N-diethylbenzamide, having the formula 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         18 . A pharmaceutical composition comprising a compound according to  claim 17 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. 
     
     
         19 . A method of treating anxiety, comprising the step of administering to a subject in need of such treatment a therapeutically effective amount of a compound according to  claim 17 , or a pharmaceutically acceptable salt thereof. 
     
     
         20 . A method of treating anxiety according to  claim 19 , wherein said anxiety is generalized anxiety disorder. 
     
     
         21 . A method of treating anxiety, comprising administering to a subject in need of such treatment a therapeutically effective amount of a composition according to  claim 18 . 
     
     
         22 . A method of treating anxiety according to  claim 21 , wherein said anxiety is generalized anxiety disorder.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.